Betapace
$ 9,00 – $ 260,00Price range: $ 9,00 through $ 260,00
Betoptic
$ 40,00 – $ 98,00Price range: $ 40,00 through $ 98,00
Betnovate
$ 40,00 – $ 55,00Price range: $ 40,00 through $ 55,00
Betnovate is a potent topical corticosteroid designed to treat a wide range of inflammatory skin conditions. This medication is commonly used to provide rapid relief from the symptoms of eczema, psoriasis, and various types of dermatitis. By targeting the source of inflammation, it significantly reduces redness, swelling, and irritation on the skin’s surface. The formula works quickly to soothe persistent itching and discomfort, helping to restore the skin’s healthy appearance. Ideal for managing localized flare-ups, Betnovate helps maintain clear and comfortable skin during dermatological challenges.
Active substance: betamethasone
SKU:
Betnovate
Category: Skin Care
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Betnovate (betamethasone valerate) belongs to a class of synthetic topical corticosteroids designed to attenuate cutaneous inflammation and pruritus. In the United States, topical betamethasone valerate preparations are available by prescription only in accordance with federal and state regulations. The medication operates by inhibiting inflammatory pathways and stabilizing lysosomal membranes within epidermal cells.
This reference guide details the clinical profile, pharmacokinetic properties, administration guidelines, and potential adverse events associated with topical betamethasone valerate. Patients should utilize this information to understand proper topical application techniques and potential drug interactions under medical guidance.
| Attribute | Details |
|---|---|
| Active Ingredient | Betamethasone valerate (0.1%) |
| Therapeutic Class | Topical Corticosteroid (Medium-to-High Potency) |
| Dosage Form | Topical cream, ointment, lotion |
| Route of Administration | Topical (cutaneous) |
| Prescription Status | Prescription (Rx) only |
| Primary Purpose | Relief of inflammatory and pruritic dermatoses |
Clinical Overview and Administration
How the drug works
Betnovate contains betamethasone valerate, a synthetic glucocorticoid with anti-inflammatory, antipruritic, and vasoconstrictive properties. At the cellular level, corticosteroids induce phospholipase A2 inhibitory proteins, collectively known as lipocortins. These proteins control the biosynthesis of potent inflammatory mediators, including leukotrienes and prostaglandins, by inhibiting the release of precursor arachidonic acid. Additionally, betamethasone valerate decreases vascular permeability and leukocyte migration into damaged tissue sites. This targeted action reduces erythema, localized edema, and skin irritation caused by various dermatological conditions.
What it’s used for
Betnovate is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Clinical indications include moderate-to-severe eczema, atopic dermatitis, plaque psoriasis (excluding widespread plaque psoriasis), lichen planus, discoid lupus erythematosus, and contact dermatitis. Topical betamethasone valerate helps manage acute exacerbations and persistent skin lesions that fail to respond adequately to lower-potency topical steroids. Off-label use for unapproved dermatological disorders must only occur under direct clinical supervision by a healthcare professional.
How it’s absorbed and eliminated
Percutaneous absorption of betamethasone valerate depends on several factors, including the integrity of the epidermal barrier, application site, formulation vehicle, and the use of occlusive dressings. Intact skin generally absorbs minimal systemic amounts, but inflamed or diseased skin exhibits increased skin penetration. Occlusive dressings significantly enhance percutaneous absorption. Once absorbed into systemic circulation, betamethasone valerate undergoes hepatic metabolism, forming inactive metabolite compounds. Elimination occurs primarily through renal excretion, with a minor proportion excreted in feces. The systemic half-life varies significantly among individuals based on systemic exposure and hepatic functionality.
Dosing schedule
Betnovate is typically applied as a thin film to the affected skin area once or twice daily, as directed by a prescribing clinician. Dosing schedules depend on the severity of the condition and the body region treated. Patients should gently rub the medication into the skin until absorbed. Occlusive dressings should not be applied unless specifically instructed by a physician. Treatment duration should be limited to the minimum time necessary to achieve clinical resolution; continuous application exceeding two to four weeks without medical re-evaluation is generally avoided to mitigate systemic absorption risks.
Practical tips
Thorough hand hygiene should precede and follow each application of Betnovate, unless the hands themselves are the targeted treatment area. Care must be taken to avoid contact with the eyes, eyelids, mouth, or open wounds. When applying the product, use only enough cream or ointment to lightly cover the lesion. Patients living in humid environments such as Houston should ensure the skin area is clean and dry prior to application to avoid localized irritation.
If you skip a dose
If an application of Betnovate is missed, it should be applied as soon as remembered. However, if it is nearly time for the next scheduled application, skip the missed dose and resume the standard application schedule. Patients should never double the amount applied or use extra medication to compensate for missed doses, as excessive application increases the likelihood of systemic corticosteroid absorption and localized skin thinning.
Safety Profile and Frequently Asked Questions
Compatibility with other medicines
Although systemic absorption of topical betamethasone valerate is low when used as directed, concurrent use with other topical medications on the same skin area should be avoided unless managed by a prescriber. Concomitant use of other systemic corticosteroids or potent CYP3A4 inhibitors (such as ritonavir or itraconazole) may decrease corticosteroid clearance, potentially elevating systemic concentrations. Applying multiple topical agents simultaneously can also alter barrier penetration or dilute the active steroid concentration, compromising therapeutic outcomes.
Adverse reactions
Localized adverse reactions associated with Betnovate application include skin burning, itching, irritation, dryness, hypertrichosis, acneiform eruptions, hypopigmentation, allergic contact dermatitis, and secondary skin infections. Prolonged or excessive use can induce skin atrophy, striae (stretch marks), telangiectasia, and perioral dermatitis. Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing’s syndrome symptoms, hyperglycemia, and glucosuria in some individuals. Any severe skin peeling or signs of systemic absorption warrant prompt medical consultation.
Important precautions
Betnovate should be used with extreme caution on thin skin areas such as the face, groin, and axillae. Pediatric patients are at higher risk for systemic HPA axis suppression and Cushing’s syndrome due to a higher skin surface area-to-body weight ratio; application in pediatric populations requires strict oversight and shortest duration. Elderly individuals may possess fragile skin, increasing susceptibility to local adverse effects. Pregnant or nursing mothers should use Betnovate only if potential benefits outweigh risks, applying minimal amounts for the shortest clinical duration possible.
Storage and expiration
Betnovate preparations should be stored at controlled room temperature, between 68°F and 77°F (20°C to 25°C), away from excessive heat, direct moisture, and light. Tightly close the tube cap after each use. Keep out of reach of children and pets. Do not freeze topical creams or lotions. Check the expiration date printed on the packaging; unused or expired medication should be disposed of in accordance with local drug take-back programs.
Common questions
Can Betnovate be applied to facial skin lesions?
Facial skin is substantially thinner and more permeable than skin on other areas of the body, making it significantly more sensitive to steroid-induced atrophy, telangiectasia, and perioral dermatitis. Application to the face should generally be avoided unless specifically prescribed by a physician. If prescribed for facial use, treatment duration is typically restricted to a few days to minimize localized side effects.
How long does it typically take for skin symptoms to improve?
Symptomatic relief, such as reductions in itching and erythema, often begins within a few days of starting treatment. However, full clinical resolution of dermatological lesions depends on the underlying disease severity and individual physiological response. If no improvement is observed after two weeks of consistent application, patients should contact their healthcare provider for diagnostic re-evaluation.
Is it safe to cover the application site with a tight bandage?
Occlusive dressings, such as plastic wraps or tight bandages, should not be applied over Betnovate unless explicitly ordered by a prescribing doctor. Occlusion increases percutaneous absorption significantly, elevating the risk of systemic corticosteroid side effects and cutaneous atrophy. Light, breathable cotton clothing over treated areas is acceptable.
Can Betnovate alter blood glucose levels in diabetic patients?
While topical betamethasone valerate is applied locally, systemic absorption can occur when used over large body surface areas or for extended periods. Systemically absorbed corticosteroids can induce hyperglycemia and impair glucose tolerance. Patients with diabetes mellitus who require extensive topical steroid therapy should monitor blood glucose levels closely under physician guidance.
What should be done if a secondary skin infection develops during treatment?
If a bacterial, fungal, or viral skin infection develops at or near the treatment site, topical corticosteroid use should be paused or accompanied by appropriate antimicrobial therapy. Corticosteroids suppress localized immune responses, which can allow cutaneous infections to spread. Patients should consult their prescriber promptly if they notice worsening redness, pus, or localized warmth.
This text is for informational purposes only and does not constitute individual medical advice.
In accordance with FDA requirements.
Additional information
| Dosage |
20g |
|---|---|
| Package |
7 tubes ,8 tubes ,9 tubes ,10 tubes |
| Ενεργός Ουσία |
Related products
A-Ret Gel
$ 50,00 – $ 141,00Price range: $ 50,00 through $ 141,00
Active substance: Tretinoin
More Details
This product has multiple variants. The options may be chosen on the product page
Adaferin Gel
$ 10,00 – $ 46,00Price range: $ 10,00 through $ 46,00
Active substance: Adapalene
More Details
This product has multiple variants. The options may be chosen on the product page
Bactroban Ointment 5g
$ 55,00 – $ 200,00Price range: $ 55,00 through $ 200,00
Active substance: Mupirocin
More Details
This product has multiple variants. The options may be chosen on the product page
Benzac AC Gel
$ 34,00 – $ 104,00Price range: $ 34,00 through $ 104,00
Active substance: benzoyl peroxide
More Details
This product has multiple variants. The options may be chosen on the product page
Betadine
$ 7,00 – $ 12,00Price range: $ 7,00 through $ 12,00
Active substance: Povidone Iodine
More Details
This product has multiple variants. The options may be chosen on the product page
Candid B Lotion
$ 40,00 – $ 85,00Price range: $ 40,00 through $ 85,00
Active substance: Beclometasone, Clotrimazole
More Details
This product has multiple variants. The options may be chosen on the product page
Decadron
$ 12,00 – $ 182,00Price range: $ 12,00 through $ 182,00
Active substance: Dexamethasone
More Details
This product has multiple variants. The options may be chosen on the product page
Fucidin cream
$ 14,00 – $ 73,00Price range: $ 14,00 through $ 73,00
Active substance: Fusidic Acid
More Details
This product has multiple variants. The options may be chosen on the product page
